Jun Hyeok Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jun Hyeok Park has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bobin Lee
Advanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea
1 shared publication Byungho Park
Advanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea
1 shared publicationChaewon Jung
Department of Chemistry, Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea
1 shared publication- Daeun Kim
Advanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea
1 shared publication Ji-Ho Park
Department of Chemistry, Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea
1 shared publicationJoon Heon Kim
Advanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 9 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Lateral flow immunoassay using plasmonic scattering
The lateral flow immunoassay (LFIA) is one of the most successful sensing platforms for real-world point-of-care (POC) testing. However, achieving PCR-level sensitivity without compromising the inherent advantages of LFIA, such as rapid and robust operation, affordability, and naked-eye detection, has remained a primary challenge. In this study, a plasmonic scattering-utilising LFIA was proposed, created by transparentising a nitrocellulose membrane and placing a light-absorbing backing card under the membrane. This LFIA minimised the background signal from its matrix, leading to substantially enhanced sensitivity and enabling naked-eye detection of the plasmonic scattering signal from gold nanoparticles without optics. Our plasmonic scattering-utilising LFIA showed an approximately 2600–4400 times higher detection limit compared with that of commercial LFIAs in influenza A assays. In addition, it exhibited 90% sensitivity in clinical validation, approaching PCR-level sensitivity, while commercial LFIAs showed 23–30% sensitivity. The plasmonic scattering-utilising LFIA plays a ground-breaking role in POC diagnostics and significantly boosts follow-up research.
- 9 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Open AccessLateral flow immunoassay using plasmonic scattering
The lateral flow immunoassay (LFIA) is one of the most successful sensing platforms for real-world point-of-care (POC) testing. However, achieving PCR-level sensitivity without compromising the inherent advantages of LFIA, such as rapid and robust operation, affordability, and naked-eye detection, has remained a primary challenge. In this study, a plasmonic scattering-utilising LFIA was proposed, created by transparentising a nitrocellulose membrane and placing a light-absorbing backing card under the membrane. This LFIA minimised the background signal from its matrix, leading to substantially enhanced sensitivity and enabling naked-eye detection of the plasmonic scattering signal from gold nanoparticles without optics. Our plasmonic scattering-utilising LFIA showed an approximately 2600–4400 times higher detection limit compared with that of commercial LFIAs in influenza A assays. In addition, it exhibited 90% sensitivity in clinical validation, approaching PCR-level sensitivity, while commercial LFIAs showed 23–30% sensitivity. The plasmonic scattering-utilising LFIA plays a ground-breaking role in POC diagnostics and significantly boosts follow-up research.